Personal Capital Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $232K | Sell |
2,796
-1,216
| -30% | -$101K | ﹤0.01% | 432 |
|
|
2022
Q3 | $318K | Buy |
4,012
+276
| +7% | +$21.9K | ﹤0.01% | 350 |
|
|
2022
Q2 | $277K | Buy |
3,736
+246
| +7% | +$18.2K | ﹤0.01% | 369 |
|
|
2022
Q1 | $314K | Sell |
3,490
-356
| -9% | -$32K | ﹤0.01% | 381 |
|
|
2021
Q4 | $431K | Sell |
3,846
-75
| -2% | -$8.41K | ﹤0.01% | 366 |
|
|
2021
Q3 | $493K | Buy |
3,921
+110
| +3% | +$13.8K | ﹤0.01% | 311 |
|
|
2021
Q2 | $516K | Sell |
3,811
-306
| -7% | -$41.4K | ﹤0.01% | 304 |
|
|
2021
Q1 | $558K | Buy |
4,117
+1,666
| +68% | +$226K | ﹤0.01% | 293 |
|
|
2020
Q4 | $345K | Sell |
2,451
-282
| -10% | -$39.7K | ﹤0.01% | 354 |
|
|
2020
Q3 | $305K | Buy |
2,733
+188
| +7% | +$21K | ﹤0.01% | 327 |
|
|
2020
Q2 | $285K | Buy |
+2,545
| New | +$285K | ﹤0.01% | 297 |
|
|
2020
Q1 | – | Sell |
-2,408
| Closed | -$229K | – | 410 |
|
|
2019
Q4 | $229K | Buy |
+2,408
| New | +$229K | ﹤0.01% | 372 |
|